Evidence map›Paper›PMID 31125077›Full record

ArticleJournal of radiation research2019

National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group.

Hiroki Kawaguchi, Toshinori Soejima, Naoya Ishibashi, Takeshi Akiba, Masatoshi Hasegawa, Kouichi Isobe, Hitoshi Ito, Michiko Imai, Yasuo Ejima, Masaharu Hata and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Low-Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Hiroki KawaguchiDivision of Radiation Oncology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo, Japan.
Toshinori SoejimaDepartment of Radiation Oncology, Kobe Proton Center, Kobe, Japan.
Naoya IshibashiDepartment of Radiology, Nihon University School of Medicine, Tokyo, Japan.
Takeshi AkibaDepartment of Radiation Oncology, Tokai University, Isehara, Japan.
Masatoshi HasegawaDepartment of Radiation Oncology, Nara Medical University, Kashihara, Japan.
Kouichi IsobeDepartment of Radiology, Toho University Sakura Medical Center, Chiba, Japan.
Hitoshi ItoDepartment of Radiation Oncology, Kyoto Katsura Hospital, Kyoto, Japan.
Michiko ImaiDepartment of Radiology, Iwata City General Hospital, Iwata, Japan.
Yasuo EjimaDepartment of Radiology, Dokkyo Medical University, Tochigi, Japan.
Masaharu HataDivision of Radiation Oncology, Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Keisuke SasaiDepartment of Radiation Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Emiko ShimodaDepartment of Radiation Oncology, Nara Medical University, Kashihara, Japan.
Masahiko OguchiDepartment of Radiation Oncology, The Cancer Institution Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Tetsuo AkimotoDivision of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan.
Nara Medical University · JPDokkyo Medical University · JPIwata City Hospital · JPJapanese Foundation For Cancer Research · JPJuntendo University · JPKobe University Hospital · JPKyoto Katsura Hospital · JPNational Cancer Center Hospital East · JPNihon University · JPToho University · JPTokai University · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI-RIST). Different institutes adopt different approaches for the administration of TBI-RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI-RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI-RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI-RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI-RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI-RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI-RIST in Japan and can assist future efforts to standardize TBI-RIST treatment methods and to design a future multicenter collaborative research study.

Indexed as

Radiation OncologyStem Cell TransplantationSurveys and QuestionnairesWhole-Body IrradiationDose-Response Relationship, RadiationHumansJapanTime Factorshematopoietic stem cell transplantationnational surveyreduced-intensity stem cell transplantationtotal-body irradiation

Identifiers

PMID31125077
PMCPMC6805977
OpenAlexW2945531115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.